Sibutramine

Chemical formula: C₁₇H₂₆ClN  Molecular mass: 279.848 g/mol  PubChem compound: 5210

Active ingredient description

Subitramine is a potent inhibitor of monoamines (serotonin, dopamine, noradrenaline) reuptake for the treatmen of obesity. Sibutramine is metabolized to metabolites M1 and M2 which are more active toward the monoamine transporters.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A08AA10 Sibutramine A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AA Centrally acting antiobesity products
Discover more medicines within A08AA10

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 106650-56-0
DrugBank Drug: DB01105
KEGG Drug: D08513
PubChem Compound: 5210
RxNorm Ingredient: 36514
SNOMED-CT Concept: 386838007
Sibutramine (substance)
UNII Identifier: OGM0YHD1WF
SIBUTRAMINE HYDROCHLORIDE
UNII Identifier: WV5EC51866
SIBUTRAMINE

Medicines

Sibutramine is an active ingredient of these brands:

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.